Related Experiment Video

Updated: Jun 8, 2026

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
06:38

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

Published on: September 12, 2019

Latest developments in targeted therapy for hepatocellular carcinoma

Liliana Montella1, Raffaele Addeo, Michele Caraglia

  • 1Medical Oncology Unit, San Giovanni di Dio Hospital, via D. Pirozzi, 80027 Frattamaggiore, Naples, Italy. lilianamontella@libero.it

Expert Review of Anticancer Therapy
|October 15, 2010
PubMed

Insights

Sorafenib marked a turning point for advanced hepatocellular carcinoma (HCC) treatment. Targeted therapies now offer selective cancer cell death, unlike traditional chemotherapy, opening new treatment avenues for this complex disease.

Area of Science:

  • Oncology
  • Hepatology
  • Pharmacology

Background:

  • Advanced hepatocellular carcinoma (HCC) historically had limited treatment options.
  • Chemotherapy showed limited efficacy and selectivity in HCC.
  • Sorafenib represented a breakthrough by targeting key signaling pathways.

Purpose of the Study:

  • To review promising targeted drugs currently under investigation for HCC.
  • To explore future therapeutic strategies for managing HCC.
  • To highlight advancements in precision medicine for liver cancer.

Main Methods:

  • Literature review of targeted therapies for HCC.
  • Analysis of clinical trial data for novel HCC drugs.
  • Discussion of pathogenetic mechanisms and signaling pathways in HCC.

Main Results:

  • Sorafenib demonstrated improved outcomes in advanced HCC.
  • Targeted drugs show potential for selective tumor cell killing.
  • Multiple novel agents are in various stages of clinical development.

Conclusions:

  • Targeted therapies are revolutionizing HCC treatment.
  • Understanding HCC's complex mutational landscape is crucial for drug development.
  • Future scenarios involve personalized treatment approaches based on molecular profiling.

More Related Videos

Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells11:08

Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells

Published on: February 14, 2025

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma12:24

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...